ISIN:AT0000785555

EQS-News: Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business

Retrieved on: 
Wednesday, April 10, 2024

Earnings after tax from continued operations were positive at EUR 24.9 million, while the loss from the medical business, which has been sold, had a significant negative impact as expected.

Key Points: 
  • Earnings after tax from continued operations were positive at EUR 24.9 million, while the loss from the medical business, which has been sold, had a significant negative impact as expected.
  • Earnings development 2023 in detail:
    The continued operations of the Semperit Group recorded revenue of EUR 721.1 million (–7.5%) in the 2023 financial year.
  • Also considering the proceeds from the sale of Examination Operations (medical business), results in EUR 111.5 million (previous year: EUR –2.8 million).
  • Overview of the main financial figures of the financial year 2023:
    Key figures of the Semperit Group, in EUR million

EQS-News: Semperit starts its 200th anniversary year

Retrieved on: 
Tuesday, January 30, 2024

Vienna, 25 January 2024 – The Semperit Group is celebrating its 200th anniversary in 2024.

Key Points: 
  • Vienna, 25 January 2024 – The Semperit Group is celebrating its 200th anniversary in 2024.
  • Founded in 1824, the company is taking this anniversary as an opportunity to highlight its centuries-long tradition but also its path to a successful future in a variety of ways under the motto “200 Years of Semperit – Experience for Tomorrow”.
  • Coupled with our Semperit spirit, which allows us to always find a solution, this has made us a reliable partner in a world that never stands still.
  • Because without our Semperit employees, our success would never have been possible.”
    Historical and current success stories from the world of Semperit will therefore be published on the 200th anniversary website throughout 2024.

EQS-News: Semperit holds its ground in a difficult market environment and has completed its repositioning as an elastomers specialist

Retrieved on: 
Saturday, December 30, 2023

Total earnings after tax thus amounted to EUR -26.8 million (1-9 2022: EUR -34.6 million).

Key Points: 
  • Total earnings after tax thus amounted to EUR -26.8 million (1-9 2022: EUR -34.6 million).
  • In the first nine months of 2023, continued operations of the Semperit Group recorded revenue of EUR 547.6 million (–7.7%).
  • Total earnings after tax (from continued and discontinued operations) amounted to EUR –26.8 million (1-9 2022: EUR –34.6 million).
  • Overview of the main financial figures of the first 9 months of 2023:
    Key performance figures of the Semperit Group, in EUR million

EQS-News: Semperit again with top ESG rating by EcoVadis

Retrieved on: 
Thursday, October 26, 2023

Vienna, 25 October 2023 – For the second time, the Semperit Group has received the highest platinum award in the EcoVadis rating for sustainability performance.

Key Points: 
  • Vienna, 25 October 2023 – For the second time, the Semperit Group has received the highest platinum award in the EcoVadis rating for sustainability performance.
  • This puts Semperit in the top one percent worldwide of more than 100,000 companies assessed by EcoVadis.
  • “The platinum award and the repeated improvement of our rating are an important confirmation for the Semperit Group and all our sites, which contribute to a more sustainable economy with their ESG initiatives.
  • Semperit clearly exceeds the industry average in all of these categories, with significant improvements achieved in ethics and sustainable procurement compared to 2022.

EQS-News: Semperit AG Holding Semperit successfully completes sale of medical business and focuses on growth in industrial core business

Retrieved on: 
Thursday, August 31, 2023

Vienna, 31 August 2023 – The Semperit Group has successfully completed the sale of its medical business to the Southeast Asian glove manufacturer HARPS GLOBAL PTE.

Key Points: 
  • Vienna, 31 August 2023 – The Semperit Group has successfully completed the sale of its medical business to the Southeast Asian glove manufacturer HARPS GLOBAL PTE.
  • “With the divestment of the medical business, we have implemented our transformation into an industrial rubber resp.
  • An important growth step has already been taken with the acquisition of the Rico Group,” says Semperit CEO Karl Haider.
  • As of 11 September 2023, the shares of Semperit AG Holding will be traded ex additional dividend.